• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Feline oral cancer is the focus of a new study

March 12, 2023

Funded by Blue Buffalo and Pet Valu, researchers with the Morris Animal Foundation will investigate squamous cell carcinoma in cats

A new study on feline oral squamous cell carcinoma is being led by Morris Animal Foundation with support from pet food suppliers Blue Buffalo and Pet Valu. The research team, led by Michelle Oblak, DVM, DVSc, DACVS, ACVS fellow of surgical oncology, at Ontario Veterinary College, University of Guelph, Canada, will explore the use of porphysome nanotechnology combined with light therapy to treat oral squamous cell carcinoma in cats.1

"Oral squamous cell carcinoma is a devastating disease in cats with limited treatment options," said Oblak, in an organizational release. "This study has the potential to unlock a new nonsurgical option for cats with oral squamous cell carcinoma. With the support of Morris Animal Foundation, we are excited to investigate this novel nanotherapy, and hope we can improve the quality of life and outcomes for these cats."

Advertisement

Oral squamous cell carcinoma is the most common oral cancer in cats, accounting for roughly 8% to 10% of all cancers diagnosed, according to the foundation. The cancer spreads locally and embeds deeply into the oral tissue. The tumors make eating and drinking difficult and very painful, and complete surgical removal is rare. Chemotherapy and radiation treatments provide only temporary relief and can have significant side effects. The average survival time is a dismal three months for cats diagnosed with this cancer.

“I cannot stress how desperately new treatments are needed for this terrible cancer,” said Kathy Tietje, PhD, MBA, vice president of scientific operations, Morris Animal Foundation, in the release. "If successful, this new treatment could have a major impact on the lives of hundreds of cats diagnosed with this aggressive tumor each year."

Cancer impacts animals worldwide and is a leading cause of death in senior cats. Since 1962, Morris Animal Foundation has funded more than 300 cancer studies, invested nearly $40 million, and continues to make strides against the disease, aided by supporting organizations.“We are very grateful for the funding Blue Buffalo and Pet Valu are providing to make this important study possible,” noted Tietje.

Reference

  1. Newly funded cat study to focus on deadly oral cancer. News release. Morris Animal Foundation. March 9, 2023. Accessed March 9, 2023. https://www.morrisanimalfoundation.org/article/feline-blue%20buffalo-oral-cancer-study

Related Content:

OncologyFeline Medicine
3 categories of inappetence in dogs
3 categories of inappetence in dogs
FDA approves generic drug for managing allergic dermatitis in cats
FDA approves generic drug for managing allergic dermatitis in cats
Chronic feline pain from all perspectives
Chronic feline pain from all perspectives

Advertisement

Latest News

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

Two pups find their forever homes while at Fetch Charlotte

View More Latest News
Advertisement